Please try another search
Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and HIV diagnostic equipment and reagents. The company was founded in 2009 and is headquartered in Yangzhou, China.
Name | Age | Since | Title |
---|---|---|---|
Guang Ji Wang | 69 | 2019 | Independent Director |
Heng Yu | 43 | 2020 | Chairman of the Supervisory Board |
Chang Qing Zhang | 54 | 2019 | Independent Director |
Yu Quan Wei | 64 | 2019 | Independent Director |
Heliang Fu | 62 | 2014 | Chairman, President & CEO |
Xiao Yan Qi | 60 | 2022 | Independent Director |
Feng Ying He | 40 | 2020 | Supervisor |
Guang Rong Wang | 46 | 2019 | VP & Director |
Lin Fang Song | 45 | 2019 | Supervisor |
Jun Wang | 48 | 2019 | VP & Director |
Ke Yu | 45 | 2020 | VP, CFO and Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review